Originally published byEU-Startups
ScreenPoint Medical, a Nijmegen-based Breast AI company focusing on breast cancer detection and risk assessment, has raised €11.9 million ($14 million) in new funding from existing investors, global software investor Insight Partners and Siemens Healthineers. It has also secured €1.7 million ($2 million) in non-dilutive research grants. With this funding, the company aims to support […]
The post Insight Partners-backed ScreenPoint Medical secures €13.6 million to advance AI-powered breast cancer detection appeared first on EU-Startups.
🌐
More news from European UnionEuropean Union
EUROPE
Related News
Intel eases reliance on TSMC with 'Merica-made Core Series 3 processors
April 17, 2026
Cloudflare can remember it for you wholesale
April 18, 2026
Opsec oopsie: Dutch navy frigate location outed by mailing it a Bluetooth tracker
April 17, 2026
Britain puts €573 million on the table as Sovereign AI names its first startup cohort
April 17, 2026
Stockholm’s BioLamina secures €20 million EIB loan to scale cell therapies for chronic diseases
April 17, 2026